Tumor eradication by adoptive transfer of cytotoxic T lymphocytes

Adv Cancer Res. 1992;58:143-75. doi: 10.1016/s0065-230x(08)60294-8.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antigens, Neoplasm / immunology
  • Antigens, Neoplasm / metabolism
  • Antigens, Viral, Tumor / immunology
  • Carcinogens
  • Clone Cells / immunology
  • Clone Cells / transplantation
  • Humans
  • Immunotherapy, Adoptive*
  • Interleukin-2 / pharmacology
  • Interleukin-2 / therapeutic use
  • Killer Cells, Lymphokine-Activated / immunology
  • Killer Cells, Lymphokine-Activated / transplantation
  • Killer Cells, Natural / immunology
  • Killer Cells, Natural / transplantation
  • Lymphocytes, Tumor-Infiltrating / immunology
  • Lymphocytes, Tumor-Infiltrating / transplantation
  • Melanoma / immunology
  • Melanoma / therapy
  • Mice
  • Neoplasms / etiology
  • Neoplasms / immunology
  • Neoplasms / pathology
  • Neoplasms / therapy*
  • Neoplasms, Experimental / etiology
  • Neoplasms, Experimental / immunology
  • Neoplasms, Experimental / pathology
  • Neoplasms, Experimental / therapy
  • Neoplasms, Radiation-Induced / immunology
  • Neoplasms, Radiation-Induced / therapy
  • Rats
  • Recombinant Proteins / pharmacology
  • Recombinant Proteins / therapeutic use
  • T-Lymphocytes, Cytotoxic / immunology
  • T-Lymphocytes, Cytotoxic / transplantation*
  • T-Lymphocytes, Regulatory / immunology
  • Tumor Virus Infections
  • Ultraviolet Rays

Substances

  • Antigens, Neoplasm
  • Antigens, Viral, Tumor
  • Carcinogens
  • Interleukin-2
  • Recombinant Proteins